Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gen-Probe buy hits Hologic's Q4 profits but set to boost future growth; analysts predict bottom-line increase for Medtronic

This article was originally published in Clinica

Executive Summary

Women's health specialist Hologic swung to a net loss during its fourth fiscal quarter as it was hit by charges relating to its $3.7bn acquisition of molecular diagnostics firm Gen-Probe, agreed in May (www.clinica.co.uk, 1 May 2012). The deal closed in August.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099657

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel